Literature DB >> 21422421

Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.

Tsung-Ying Yang1, Chi-Ren Tsai, Kun-Chieh Chen, Kuo-Hsuan Hsu, Hsien-Ming Lee, Gee-Chen Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21422421     DOI： 10.1200/JCO.2010.33.5802

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.

Authors:  Gou Yamamoto; Mari Kikuchi; Shiho Kobayashi; Yoshiko Arai; Kenji Fujiyoshi; Tomokazu Wakatsuki; Miho Kakuta; Yuki Yamane; Yoshihito Iijima; Hideaki Mizutani; Yuki Nakajima; Junko Sudo; Hiroyasu Kinoshita; Futoshi Kurimoto; Hirohiko Akiyama; Hidetaka Uramoto; Hiroshi Sakai; Yoshito Akagi; Kiwamu Akagi
Journal:  Int J Oncol       Date:  2017-03-27       Impact factor: 5.650

2.  Machine learning-based algorithm demonstrates differences in del19 and L858R EGFR subgroups in non-small cell lung cancer: a single center experience.

Authors:  Ullas Batra; Shrinidhi Nathany; Mansi Sharma; Anurag Mehta; Surender Dhanda; Joslia T Jose
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

3.  Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.

Authors:  George Santis; Roger Angell; Guillermina Nickless; Alison Quinn; Amanda Herbert; Paul Cane; James Spicer; Ronan Breen; Emma McLean; Khalid Tobal
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

4.  Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.

Authors:  Stefano Frega; Martina Lorenzi; Matteo Fassan; Stefano Indraccolo; Fiorella Calabrese; Adolfo Favaretto; Laura Bonanno; Valentina Polo; Giulia Zago; Francesca Lunardi; Ilaria Attili; Alberto Pavan; Massimo Rugge; Valentina Guarneri; PierFranco Conte; Giulia Pasello
Journal:  Oncotarget       Date:  2017-05-16

5.  The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.

Authors:  Liming Cao; Long Long; Min Li; Huaping Yang; Pengbo Deng; Xinru Mao; Jianxing Xiang; Bing Li; Tengfei Zhang; Chengping Hu
Journal:  Onco Targets Ther       Date:  2018-05-08       Impact factor: 4.147

6.  The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review.

Authors:  Bao-Dong Qin; Xiao-Dong Jiao; Ling-Yan Yuan; Ke Liu; Zhan Wang; Wen-Xing Qin; Yuan-Sheng Zang
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

7.  First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution's clinical practice experience.

Authors:  Xiangyang Yu; Xuewen Zhang; Zichen Zhang; Yongbin Lin; Yingsheng Wen; Yongqiang Chen; Weidong Wang; Lanjun Zhang
Journal:  Cancer Commun (Lond)       Date:  2018-07-28

8.  Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma.

Authors:  Jeng-Sen Tseng; Chih-Liang Wang; Ming-Shyan Huang; Chung-Yu Chen; Cheng-Yu Chang; Tsung-Ying Yang; Chi-Ren Tsai; Kun-Chieh Chen; Kuo-Hsuan Hsu; Meen-Hsin Tsai; Sung-Liang Yu; Kang-Yi Su; Chih-Wei Wu; Cheng-Ta Yang; Yuh-Min Chen; Gee-Chen Chang
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

9.  [Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor 
Receptor Mutations in Non-small Cell Lung Cancer].

Authors:  Xue Yang; Hanxiao Chen; Hong Zhang; Jianchun Duan; Tongtong An; Jun Zhao; Minglei Zhuo; Meina Wu; Jie Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-08

10.  Efficacy of afatinib for pulmonary adenocarcinoma with leptomeningeal metastases harboring an epidermal growth factor receptor complex mutation (exon 19del+K754E): A case report.

Authors:  Chunhua Ma; Mei Liu; Ning Mu; Jinduo Li; Lin Li; Rong Jiang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.